The aim of the project was the acquisition of the Advia Centaur® XPT immunochemical automate system manufactured by Siemens, followed by the adaptation of the test assays provided by the instrument.
Avidin can simultaneously check for Covid-19 and Influenza infection from the same specimen by using its multi-diagnostic PCR solution with high specificity and sensitivity.
Avidin, led by Dr. Liliana Fehér, has developed its own one-step RT-PCR kit, the Cov2QuantTM SARS-Cov-2 Quantification kit (cat: CQ-100), designed to detect the novel corona virus, SARS-Cov-2, quantitatively by using reverse trascription reaction and quantitative real-time polymerase chain reaction.
Avidin has expanded the company’s portfolio with a specialized clinical molecular diagnostics department focused on the detection and monitoring of infectious diseases.
Avidin set up viral diagnostics lab and developed own reagents and method to combat Covid-19 reported by HVG 05/28/2020 Avidin, reported by HVG (Weekly World
Novel SARS-CoV-2 vaccine program 04/07/2020 Avidin´s novel SARS-CoV-2 vaccine program has been funded by National Research, Development and Innovation Office Project identification number: 2020-2.1.1.-ED-2020-00015Project title:
Avidin’s laboratories, both Szeged headquarter and Budapest site are MSZ EN ISO 9001:2015 certified
Avidin together with partner Synaptogenex awarded with Market-leaded Research Development and Innovation Support 20.01.2020 Project title: Development, testing and production of active compounds and functional
Avidin demonstrates in Molecular Sciences Immunomodulatory Effect of Cisplatin explored with Single Cell Mass Cytometry 12.25.2019 Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of
